{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:55:42Z","timestamp":1793656542559,"version":"4.5.1"},"reference-count":63,"publisher":"American Society for Clinical Investigation","issue":"13","funder":[{"name":"Medical Research Council","award":["Confidence in Concept"],"award-info":[{"award-number":["Confidence in Concept"]}]},{"name":"Life Sciences Bridging Fund Pathfinder Award","award":["LSBF\/R6-010"],"award-info":[{"award-number":["LSBF\/R6-010"]}]},{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"crossref","award":["20281"],"award-info":[{"award-number":["20281"]}],"id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,9]]},"abstract":"<jats:p>Musculoskeletal disorders represent the third greatest burden in terms of death and disability in the developed world. Osteoarthritis is the single greatest cause of chronic pain, has no cure, and affects 8.5 and 27 million people in the UK and US, respectively. Osteoarthritis is most prevalent in older people, but as it commonly occurs after joint injury, young people with such injuries are also susceptible. Painful joints are often treated with steroid or hyaluronic acid (HA) injections, but treatments to prevent subsequent joint degeneration remain elusive. In animals, joint injury increases glutamate release into the joint, acting on nerves to cause pain, and joint tissues to cause inflammation and degeneration. This study investigated synovial fluid glutamate concentrations and glutamate receptor (GluR) expression in injured human joints and compared the efficacy of GluR antagonists with current treatments in a mouse model of injury-induced osteoarthritis (ACL rupture). GluRs were expressed in the ligaments and meniscus after knee injury, and synovial fluid glutamate concentrations ranged from 19 to 129 \u03bcM. Intra-articular injection of NBQX (GluR antagonist) at the time of injury substantially reduced swelling and degeneration in the mouse ACL rupture model. HA had no effect, and Depo-Medrone reduced swelling for 1 day but increased degeneration by 50%. Intra-articular administration of NBQX modified both symptoms and disease to a greater extent than current treatments. There is an opportunity for repurposing related drugs, developed for CNS disorders and with proven safety in humans, to prevent injury-induced osteoarthritis. This could quickly reduce the substantial burden associated with osteoarthritis.<\/jats:p>","DOI":"10.1172\/jci.insight.134055","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T12:06:32Z","timestamp":1592309192000},"source":"Crossref","is-referenced-by-count":19,"title":["AMPA\/kainate glutamate receptor antagonists prevent posttraumatic osteoarthritis"],"prefix":"10.1172","volume":"5","author":[{"given":"Cleo S.","family":"Bonnet","sequence":"first","affiliation":[{"name":"School of Biosciences,"},{"name":"Biomechanics and Bioengineering Research Centre Versus Arthritis, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie J.","family":"Gilbert","sequence":"additional","affiliation":[{"name":"School of Biosciences,"},{"name":"Biomechanics and Bioengineering Research Centre Versus Arthritis, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma J.","family":"Blain","sequence":"additional","affiliation":[{"name":"School of Biosciences,"},{"name":"Biomechanics and Bioengineering Research Centre Versus Arthritis, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6118-020X","authenticated-orcid":true,"given":"Anwen S.","family":"Williams","sequence":"additional","affiliation":[{"name":"Biomechanics and Bioengineering Research Centre Versus Arthritis, and"},{"name":"School of Medicine, Cardiff University, Cardiff, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4926-3365","authenticated-orcid":true,"given":"Deborah J.","family":"Mason","sequence":"additional","affiliation":[{"name":"School of Biosciences,"},{"name":"Biomechanics and Bioengineering Research Centre Versus Arthritis, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2020,7,9]]},"reference":[{"issue":"Suppl 1","key":"B1","article-title":"Global burden of osteoarthritis and musculoskeletal diseases","volume":"16","author":"Woolf","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"key":"B2","unstructured":"[No authors listed]. Arthritis. National Health Service. http:\/\/www.nhs.uk\/conditions\/arthritis\/pages\/introduction.aspx#osteo Accessed June 4, 2020"},{"key":"B3","unstructured":"[No authors listed]. NHS England Programme Budgeting Data (2012-3). National Health Service. http:\/\/www.england.nhs.uk\/resources\/resources-for-ccgs\/prog-budgeting\/ Accessed June 4, 2020"},{"key":"B4","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/698709","article-title":"The global economic cost of osteoarthritis: how the UK compares","volume":"2012","author":"Chen","year":"2012","journal-title":"Arthritis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210146"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/art.24984"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/art.39465"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/01.bot.0000246468.80635.ef"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2016.03.026"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1177\/0363546508316770"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1177\/0363546507307396"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.csm.2012.08.017"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2106\/00004623-199611000-00006"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jse.2006.03.011"},{"issue":"1","key":"B15","first-page":"104","article-title":"Post-traumatic ankle arthritis","volume":"71","author":"Weatherall","year":"2013","journal-title":"Bull Hosp Jt Dis (2013)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/ar4476"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/jor.22972"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/jor.22940"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1186\/ar4591"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2015.03.017"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203670"},{"issue":"3","key":"B23","first-page":"739","article-title":"Excitatory amino acid profiles of synovial fluid from patients with arthritis","volume":"27","author":"McNearney","year":"2000","journal-title":"J Rheumatol"},{"issue":"1-2","key":"B24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0304-3959(99)00311-5","article-title":"Amino acid release into the knee joint: key role in nociception and inflammation","volume":"86","author":"Lawand","year":"2000","journal-title":"Pain"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.orthres.2004.12.015"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2003.08.009"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2015.02.001"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1172\/JCI44911"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2004.02563.x"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00452.2009"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/art.22829"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/art.10943"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1159\/000329551"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1159\/000213866"},{"key":"B35","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.joca.2003.09.007","article-title":"Subchondral bone changes in hand and knee osteoarthritis detected by radiography","volume":"12 Suppl A","author":"Buckland-Wright","year":"2004","journal-title":"Osteoarthr Cartil"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2005.08.007"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1172\/JCI867"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/36.1.16"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/BF02555898"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1997.12.4.641"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2011.571218"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1177\/03635465980260031101"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/jor.23872"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2012.04.014"},{"issue":"2","key":"B45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0090-9556(25)08371-0","article-title":"Pharmacokinetics of the neuroprotective glutamate antagonist NBQX (6-nitro-7-sulfamoyl-benzo(f)quinoxaline-2,3-dione) in mice, rats, and dogs. Interactions with probenecid","volume":"22","author":"Dalgaard","year":"1994","journal-title":"Drug Metab Dispos"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2014.09.006"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/jps.21346"},{"issue":"5","key":"B48","doi-asserted-by":"crossref","DOI":"10.1177\/2325967115581163","article-title":"The effect of intra-articular corticosteroids on articular cartilage: a systematic review","volume":"3","author":"Wernecke","year":"2015","journal-title":"Orthop J Sports Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.22203\/eCM.v034a21"},{"issue":"10","key":"B50","article-title":"Intra-articular corticosteroid for knee osteoarthritis","author":"J\u00fcni","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"B51"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2012.01.017"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000412"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/art.27765"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2007.03.017"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2008.04.013"},{"issue":"7","key":"B57","article-title":"Synovial fluid analysis in dogs with elbow, hip and stifle joint disorders","volume":"1","author":"Anirudh","year":"2015","journal-title":"Int J Appl Pure Sci Agric"},{"issue":"12","key":"B58","first-page":"342","article-title":"Characteristics of normal equine tarsal synovial fluid","volume":"31","author":"Van Pelt","year":"1967","journal-title":"Can J Comp Med Vet Sci"},{"key":"B59","unstructured":"[No authors listed]. Depo-Medrone 40mg\/mL PL 00057\/0963. DataPharm. https:\/\/www.medicines.org.uk\/emc\/product\/8957\/smpc Accessed June 4, 2020"},{"key":"B60","unstructured":"[No authors listed]. Depo-Medrone V 40 mg\/mL Suspension for Injection. NOAH Compendium. http:\/\/www.noahcompendium.co.uk\/?id=-456912 Accessed June 4, 2020"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.182.1.613"},{"key":"B62","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.joca.2010.05.025","article-title":"The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse","volume":"18 Suppl 3","author":"Glasson","year":"2010","journal-title":"Osteoarthr Cartil"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1177\/0023677214559627"}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/134055\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:13:11Z","timestamp":1779192791000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/134055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,9]]},"references-count":63,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2020,7,9]]},"published-print":{"date-parts":[[2020,7,9]]}},"alternative-id":["10.1172\/jci.insight.134055"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.134055","relation":{},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,9]]},"article-number":"e134055"}}